首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Geographic differences in access to transplantation in the United States.
【24h】

Geographic differences in access to transplantation in the United States.

机译:在美国获得移植的地域差异。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The Etablissement francais des Greffes reports regional variability in access to organ transplantation in France. Some variability seems to be inevitable for reasons discussed in the French article. We provide comparative data on a similar phenomenon in the United States, including some historical perspectives and recent attempts to minimize geographic variability especially for patients in urgent need of liver transplants. METHODS: To assess regional variability in access to heart, liver, and kidney transplants, a competing risks method was used. Outcomes were examined for primary transplant candidates added to the waiting list during 3-year periods. Results were stratified by region of listing. RESULTS: Four months after listing, the transplant rate for all U.S. kidney transplant candidates was 10.9%. Regionally the 4-month transplant rate ranged from 4.2% to 18.5% for highly sensitized patients and from 5.4% to 19.6% for nonsensitized patients. For liver candidates, the overall national transplant rate 4 months after listing was 22%, but the overall regional rate varied from 11.8% to 36.5%. The overall transplant rate for heart candidates 4 months after listing was 43.9%, whereas regional 30-day transplant rates for the most urgent heart candidates (status 1A) ranged from 25.1% to 47.1%. Four-month transplant rates for less urgent heart candidates ranged from 24.9% to 40.7%. CONCLUSION: Similar to the French experience, pretransplantation waiting times in the 11 U.S. regions vary considerably. Computer-simulated modeling shows that redrawing organ distribution boundaries could reduce but not eliminate geographic variability. It may be too early to tell whether the recently implemented Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease liver allocation system will decrease regional variability in access to transplant as compared with the previous system.
机译:背景:法国自由行报道了法国器官移植途径的地区差异。由于法语文章中讨论的原因,某些可变性似乎是不可避免的。我们提供了在美国类似现象的比较数据,包括一些历史观点和最近为最大程度地降低地理变异性而进行的尝试,特别是对于急需肝移植的患者。方法:为了评估获得心脏,肝脏和肾脏移植物的区域变异性,使用了竞争风险方法。在三年期间检查了结果,以将其纳入候补名单中。结果按上市地区分类。结果:上市后四个月,所有美国肾脏移植候选者的移植率为10.9%。从地区来看,高敏患者的4个月移植率在4.2%至18.5%之间,非敏锐患者的从4%至19.6%。对于肝脏候选药物,上市后4个月的总体国家移植率为22%,但总体区域移植率从11.8%至36.5%不等。上市后4个月心脏候选者的总移植率为43.9%,而最紧急心脏候选者(状态1A)的30天区域移植率为25.1%至47.1%。不太紧急的心脏候选者的四个月移植率在24.9%至40.7%之间。结论:与法国的经验相似,美国11个地区的移植前等待时间相差很大。计算机模拟的模型表明,重新绘制器官分布边界可以减少但不能消除地理变异性。现在断言最近实施的终末期肝病/小儿终末期肝病模型肝脏分配系统是否会比以前的系统减少区域性差异还为时过早。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号